Scoop has an Ethical Paywall
Licence needed for work use Learn More

World Video | Defence | Foreign Affairs | Natural Events | Trade | NZ in World News | NZ National News Video | NZ Regional News | Search

 

Western Powers Have Lost The Vaccine Diplomacy Battle

New report by The Economist Intelligence Unit (The EIU) outlines strategy, goals and risks behind Russia and China’s successful vaccine diplomacy drive.

  • China and Russia have been sending millions of doses of coronavirus vaccines to developing states in recent months.
  • Through this “vaccine diplomacy” operation, Russia and China aim to strengthen their global presence and boost relations with emerging countries.
  • Russia and China are aiming to take advantage of a “vaccine vacuum”—a perceived failure of Western states to help in the provision of vaccines.
  • Russia and China are playing a long game with vaccine diplomacy. Their intention is to cement their influence over the long term.
  • Assistance in the form of vaccines will often come with economic or political strings attached.
  • China and Russia are focusing on regions where they are courting favours, competing with Western powers, or where they have a limited presence.
  • By contrast, Western powers like the EU and the US have so far mostly been absent from the vaccine diplomacy scene.
  • It is likely that the damage to the reputation of Western countries has already been done and will be hard to repair.

With vaccine diplomacy, Russia and China are gaining leverage on the cheap while fulfilling commercial goals. In most cases, they are not donating vaccines, but selling them; in China’s case, state-owned firms are competing with private ones for the supply of shots.

Advertisement - scroll to continue reading

China and Russia are focusing their efforts on regions where they are courting favours from emerging countries (for instance Asia for China), or directly competing with Western powers for influence (such as eastern Europe, and in particular the western Balkans, for both China and Russia), or in regions where they have only a limited presence so far (as is the case for Latin America, which is traditionally within America’s sphere of influence).

Vaccine diplomacy comes with risks. In Russia, and to a lesser extent also in China, conflicting priorities between vaccinating the domestic population and exporting shots will remain acute throughout 2021. To tackle this issue, both countries are opening additional factories (at home and abroad). However, it is unlikely that extra production lines will help to ease supply issues before the second half of 2021; setting up vaccine factories is technically challenging and it takes a minimum of six months before they are operational.

In the coming years, this will reinforce the global standing and leverage of Russia and China in emerging countries, helping both countries to gain influence and pursue their interests around the world. The longer term consequence of today’s vaccine diplomacy will be a further fragmentation of the global order.

Agathe Demarais, The EIU’s global forecasting director and author of the report, says:

“With vaccine diplomacy, Russia and China seek to leverage resentment against Western countries, which have pre-booked more than half of the global supply of vaccines this year and are prioritising immunising their own populations.

Ms Demarais adds that “Vaccine diplomacy is not about sending shots as a one-off operation. Both Russia and China are establishing vaccine facilities across the world and training local workers from emerging countries, betting that such a strategy will boost their presence on the ground for decades to come.”

Finally, Ms Demarais mentions that “Western countries will only engage in vaccine diplomacy only later this year. This will likely be too late to catch up with that of Russia and China, which are winning the public relations battle.”

MAP OF GLOBAL VACCINATION TIMELINES:

Methodology:

This map depicts the latest forecasts from The EIU for the rollout of coronavirus vaccines, reflecting the time when countries may expect to have vaccinated the majority (60-70%) of their adult population. Criteria taken into account include supply deals, production constraints, vaccine hesitancy, the size of the population, and the availability of healthcare workers. The data are also adjusted by analysts to reflect specific conditions on the ground.

MAP OF RUSSIA AND CHINA’S VACCINE DIPLOMACY:

Download the EIU’s latest report here.

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
World Headlines

 
 
 
 
 
 
 
 
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.